Mark Solter

Mark Solter

Cleveland Clinic - Cleveland / United States
Others
AD Scientific Index ID: 5505006
person_outline Mark Solter's MOST POPULAR ARTICLES
1-) Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair–proficient metastatic colorectal cancerNH Segal, A Cercek, G Ku, AJ Wu, A Rimner, DN Khalil, D Reidy-Lagunes, ...Clinical Cancer Research 27 (8), 2200-2208, 2021612021
2-) Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose RadiationC Billena, ML Solter, P Qi, CS Shah, JS YuInternational Journal of Radiation Oncology, Biology, Physics 120 (2), e219, 20242024
3-) Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC).E Harrold, M Solter, HS Walch, WK Chatila, F Keane, MA Lumish, ...Journal of Clinical Oncology 40 (16_suppl), 3613-3613, 20222022